Neil Kumar, CEO: BridgeBio Pharma BBIO Sell · Filed 25/08/22

Trade details

Type: Insider sale
Amount: $1,255,783.68
Shares · price: 25,728 sh · $48.81 a share
Held after: 223,518 sh
Stock: BridgeBio Pharma BBIO
Person: Neil KumarCEO
Trade date: 25/08/20
Filed: 25/08/22
Days to filing: 2 days

Sold 10.3% of holdings

Share of holding sold: 10.3%

BridgeBio Pharma trades, last 26 weeks

What else happened in BridgeBio Pharma around then

Filed or reported within 30 days of the trade day · 25/07/21~25/09/19

Neil Kumar's recent trades

Neil KumarDirector, Officer
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 plan
BridgeBio Pharma
BBIO
$2.5M
30,000 sh
$2.5M
Filed 08/19
Traded 08/19
Neil KumarDirector, Officer
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 plan
BridgeBio Pharma
BBIO
$2.8M
34,980 sh
$2.8M
Filed 08/18
Traded 08/18
Neil KumarCEO
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$1.1M
15,921 sh
$1.1M
Filed 06/08
Traded 06/04
Neil KumarCEO
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$1.1M
15,921 sh
$1.1M
Filed 06/08
Traded 06/04
Neil KumarCEO
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$572.7K
8,437 sh
$572.7K
Filed 06/08
Traded 06/05